Previsioni del mercato degli aghi cardiovascolari nell’Asia del Pacifico fino al 2028 – Impatto del COVID-19 e analisi regionale per tipologia (aghi a corpo tondo e aghi taglienti); Applicazione (chirurgia a cuore aperto e procedure valvolari cardiache); Utilizzo (uso singolo e usi multipli); Utente finale (ospedali e cliniche, centri chirurgici ambulatoriali e centri cardiovascolari)
Introduzione al mercato
Gli aghi cardiovascolari vengono utilizzati durante una serie di interventi chirurgici cardiovascolari come la chirurgia a cuore aperto, le procedure sulle valvole cardiache, il trapianto di cuore , l\'intervento chirurgico di bypass dell\'arteria coronaria e molti altri interventi chirurgici necessitano di aghi chirurgici. Questi aghi cardiovascolari sono di due tipi: aghi monouso o senza cruna e aghi multiuso o con cruna. Gli aghi cardiovascolari sono prodotti con nuove leghe di acciaio inossidabile contenenti alte concentrazioni di nichel, Surgalloy ed Ethalloy.
Pertanto, si prevede che la crescente prevalenza di malattie cardiovascolari creerà una domanda significativa di aghi cardiovascolari nei prossimi anni. anni, che si prevede guiderà ulteriormente il mercato degli aghi cardiovascolari.
L\'epidemia ha gravemente colpito il settore del turismo medico nell\'Asia del Pacifico e ha imposto interruzioni della catena di approvvigionamento; inoltre, i paesi a basso reddito si trovano ad affrontare ulteriori sfide dovute alla carenza di infrastrutture sanitarie, alle restrizioni imposte dagli ospedali ai fornitori, alla diminuzione della domanda di strumenti chirurgici cardiovascolari e altro. Misure restrittive sono state adottate in Corea del Sud, Malesia, Singapore, Filippine e India per prevenire la trasmissione della malattia. Si prevede che queste misure restrittive avranno un impatto sulla catena di approvvigionamento e sulla disponibilità di dispositivi medici in questi paesi. Ha avuto ripercussioni sui redditi disponibili e ha provocato anche disoccupazione. Inoltre, le strategie aziendali come acquisizioni, fusioni e partnership sono influenzate negativamente dall’imposizione del blocco completo. Si prevede che tali ostacoli alle attività commerciali ostacolino la produzione e la distribuzione di diversi strumenti chirurgici cardiovascolari. Tuttavia, si prevede che l\'aumento della vaccinazione in tutta la regione e la disponibilità di politiche di rimborso governative per varie procedure cardiovascolari normalizzeranno la situazione nella regione dell\'Asia del Pacifico e aumenteranno gradualmente la domanda di aghi cardiovascolari.
Panoramica e dinamiche del mercato
Il mercato degli aghi cardiovascolari nella regione Asia-Pacifico è si prevede che crescerà da 18.861,5 migliaia di dollari nel 2021 a 31.968,6 migliaia di dollari entro il 2028; si stima che crescerà a un CAGR del 7,8% dal 2021 al 2028. La prevalenza delle condizioni cardiovascolari è in aumento in modo significativo nei paesi in via di sviluppo a causa del cambiamento dello stile di vita e della modernizzazione delle infrastrutture commerciali, industriali e residenziali; le strutture modernizzate comportano una riduzione delle attività fisiche. D’altro canto, i livelli di stress continuano ad aumentare tra le persone. Pertanto, questi fattori stanno guidando la prevalenza delle condizioni cardiovascolari nei paesi in via di sviluppo. Inoltre, questi paesi stanno sviluppando in modo significativo le proprie strutture e servizi sanitari e si stanno dirigendo verso progressi tecnologici. Ad esempio, il cuore strutturale è nelle fasi iniziali di sviluppo nell’Asia del Pacifico, nel Medio Oriente e in Africa. In India, il Kim Hospital fornisce servizi terapeutici per le malattie cardiache strutturali. Secondo lo studio Global Burden of Disease pubblicato su Lancet, circa 10 decessi in tutto il mondo sono associati a questa malattia, il che equivale a circa 6,4 milioni di decessi. Cina, India, Stati Uniti e Russia hanno contribuito collettivamente per circa il 50% a questo numero nel 2015. Inoltre, secondo la statistica, è probabile che l\'incidenza delle malattie cardiache strutturali aumenterà in Asia nei prossimi anni.
< p>Segmenti chiave del mercato
In termini di tipologia, il segmento degli aghi a corpo tondo ha rappresentato il segmento più grande quota del mercato degli aghi cardiovascolari nell’Asia del Pacifico nel 2020. In termini di applicazione, il segmento della chirurgia a cuore aperto ha rappresentato la quota maggiore del mercato degli aghi cardiovascolari nell’Asia del Pacifico nel 2020. In termini di utilizzo, il segmento monouso ha rappresentato la quota maggiore quota del mercato degli aghi cardiovascolari nell\'Asia del Pacifico nel 2020. In termini di utente finale, il segmento degli ospedali e delle cliniche ha rappresentato la quota maggiore del mercato degli aghi cardiovascolari nell\'Asia del Pacifico nel 2020.
Principali fonti e aziende elencate
Alcune principali fonti primarie e secondarie Per la preparazione di questo rapporto sul mercato degli aghi cardiovascolari nell’Asia del Pacifico si fa riferimento, tra gli altri, ai siti Web aziendali, ai rapporti annuali, ai rapporti finanziari, ai documenti governativi nazionali e ai database statistici. Le principali aziende elencate nel rapporto sono Ethicon (Johnson & Johnson Services, Inc.), MANI, INC., Barber of Sheffield, FSSB chirurgico aghi GmbH, Medtronic, Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., Aurolab, CP Medical e SMB Corporation of India.
Rapporto sui motivi per acquistare
- Comprendere il panorama del mercato degli aghi cardiovascolari nell\'Asia del Pacifico e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte rendimento
- Stare al passo con la concorrenza comprendendo il panorama competitivo in continua evoluzione per il mercato degli aghi cardiovascolari nell\'Asia del Pacifico li>
- Pianificare in modo efficiente operazioni di fusione e acquisizione e accordi di partnership nel mercato degli aghi cardiovascolari nell\'Asia del Pacifico identificando i segmenti di mercato con le vendite probabili più promettenti
- Aiuta a prendere decisioni aziendali consapevoli grazie a un\'analisi perspicace e completa delle prestazioni del mercato di vari segmenti del mercato degli aghi cardiovascolari nell\'Asia del Pacifico
- Ottieni previsioni sui ricavi di mercato per i vari segmenti dal 2021 al 2028 nella regione dell\'Asia del Pacifico.
Segmentazione del mercato degli aghi cardiovascolari nell\'Asia Pacifico
Per Applicazione
- Apri Chirurgia cardiaca
- Procedure sulle valvole cardiache
Per utilizzo
- Uso singolo
- Usi multipli
Per utente finale
- Ospedali e cliniche
- Centri chirurgici ambulatoriali
- Centri cardiovascolari
Per paese
- Asia Pacifico
- Cina
- Giappone
- India
- Corea del Sud
- Australia
- Resto dell\'Asia Pacifico
Aziende menzionate
- Ethicon (Johnson & Johnson Services, Inc.)
- MANI, INC
- Barbiere di Sheffield
- Aghi chirurgici FSSB GmbH
- Medtronic
- Teleflex Incorporated
- Meril Life Sciences Pvt. Ltd.
- CP Medical
- SMB Corporation of India
- Aurolab
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Cardiovascular Needle Market – By Type
1.3.2 Cardiovascular Needle Market – By Application
1.3.3 Cardiovascular Needle Market – By Usage
1.3.4 Cardiovascular Needle Market – By End User
1.3.5 Asia Pacific Cardiovascular Needle Market – By Country
2. Asia Pacific Cardiovascular Needle Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Cardiovascular Needle Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cardiovascular Needle Market- Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Cardiovascular Needle Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Cardiovascular Diseases
5.1.2 Rise in Elderly Population
5.2 Key Market Restraints
5.2.1 Preference for Surgical Staples over Needles
5.3 Key Market Opportunities
5.3.1 Growth Opportunities in Developing Nations
5.4 Future Trends
5.4.1 Proliferation of MedTech Industry
5.5 Impact Analysis
6. Cardiovascular Needle Market – Asia Pacific Analysis
6.1 Asia Pacific Cardiovascular Needle Market Revenue Forecasts and Analysis
7. Asia Pacific Cardiovascular Needle Market Analysis and Forecasts To 2028 – By Type
7.1 Overview
7.2 Cardiovascular Needle Market Revenue Share, by Type (2020 and 2028)
7.3 Round-Bodied Needles
7.3.1 Overview
7.3.2 Round-Bodied Needles: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
7.4 Cutting Needles
7.4.1 Overview
7.4.2 Cutting Needles: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
8. Asia Pacific Cardiovascular Needle Market Analysis and Forecasts To 2028 – By Application
8.1 Overview
8.2 Cardiovascular Needle Market Revenue Share, by Application (2020 and 2028)
8.3 Open Heart Surgery
8.3.1 Overview
8.3.2 Open Heart Surgery: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
8.4 Cardiac Valve Procedures
8.4.1 Overview
8.4.2 Cardiac Valve Procedures: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
9. Asia Pacific Cardiovascular Needle Market Analysis and Forecasts To 2028 – By Usage
9.1 Overview
9.2 Cardiovascular Needle Market Revenue Share, by Usage (2020 and 2028)
9.3 Single Use
9.3.1 Overview
9.3.2 Single Use: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
9.4 Multiple Use
9.4.1 Overview
9.4.2 Multiple Use: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
10. Asia Pacific Cardiovascular Needle Market Analysis and Forecasts To 2028 –By End user
10.1 Overview
10.2 Cardiovascular Needle Market Revenue Share, by End User (2020 and 2028)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
10.4 Ambulatory Surgical Centers
10.4.1 Overview
10.4.2 Ambulatory Surgical Centers: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
10.5 Cardiovascular Centers
10.5.1 Overview
10.5.2 Cardiovascular Centers: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
11. Cardiovascular Needle Market Revenue and Forecasts to 2028 – Geographical Analysis
11.1 Asia Pacific: Cardiovascular Needle Market
11.1.1 Overview
11.1.2 Asia Pacific: Cardiovascular Needle Market, by Country, 2021 & 2028 (%)
11.1.2.1 China: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.1.1 China: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.1.2 China: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)
11.1.2.1.3 China: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)
11.1.2.1.4 China: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)
11.1.2.1.5 China: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)
11.1.2.2 Japan: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.2.1 Japan: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.2.2 Japan: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)
11.1.2.2.3 Japan: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)
11.1.2.2.4 Japan: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)
11.1.2.2.5 Japan: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)
11.1.2.3 India: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.3.1 India: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.3.2 India: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)
11.1.2.3.3 India: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)
11.1.2.3.4 India: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)
11.1.2.3.5 India: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)
11.1.2.4 Australia: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.4.1 Australia: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.4.2 Australia: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)
11.1.2.4.3 Australia: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)
11.1.2.4.4 Australia: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)
11.1.2.4.5 Australia: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)
11.1.2.5 South Korea: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.5.1 South Korea: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.5.2 South Korea: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)
11.1.2.5.3 South Korea: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)
11.1.2.5.4 South Korea: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)
11.1.2.5.5 South Korea: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)
11.1.2.6 Rest of Asia Pacific: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.6.1 Rest of Asia Pacific: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
11.1.2.6.2 Rest of Asia Pacific: Cardiovascular Needle Market, By Type, 2019–2028 (USD Thousands)
11.1.2.6.3 Rest of Asia Pacific: Cardiovascular Needle Market, by Application, 2019–2028 (USD Thousands)
11.1.2.6.4 Rest of Asia Pacific: Cardiovascular Needle Market, by Usage, 2019–2028 (USD Thousands)
11.1.2.6.5 Rest of Asia Pacific: Cardiovascular Needle Market, by End User, 2019–2028 (USD Thousands)
12. Impact Of COVID-19 Pandemic on Asia Pacific Cardiovascular Needle Market
12.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
13. Industry Landscape
13.1 Overview
14. Company Profiles
14.1 Ethicon (Johnson & Johnson Services, Inc.)
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 MANI,INC
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Barber of Sheffield
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 FSSB surgical needles GmbH
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Medtronic
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Teleflex Incorporated
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Meril Life Sciences Pvt. Ltd.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 CP Medical
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 SMB Corporation of India
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Aurolab
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. China: Cardiovascular Needle Market, By Type – Revenue and Forecast to 2028 (USD Thousands)
Table 2. China: Cardiovascular Needle Market, by Application – Revenue and Forecast to 2028 (USD Thousands)
Table 3. China: Cardiovascular Needle Market, by Usage– Revenue and Forecast to 2028 (USD Thousands)
Table 4. China: Cardiovascular Needle Market, by End User– Revenue and Forecast to 2028 (USD Thousands)
Table 5. Japan: Cardiovascular Needle Market, By Type– Revenue and Forecast to 2028 (USD Thousands)
Table 6. Japan: Cardiovascular Needle Market, by Application– Revenue and Forecast to 2028 (USD Thousands)
Table 7. Japan: Cardiovascular Needle Market, by Usage – Revenue and Forecast to 2028 (USD Thousands)
Table 8. Japan: Cardiovascular Needle Market, by End User – Revenue and Forecast to 2028 (USD Thousands)
Table 9. India: Cardiovascular Needle Market, By Type– Revenue and Forecast to 2028 (USD Thousands)
Table 10. India: Cardiovascular Needle Market, by Application – Revenue and Forecast to 2028 (USD Thousands)
Table 11. India: Cardiovascular Needle Market, by Usage– Revenue and Forecast to 2028 (USD Thousands)
Table 12. India: Cardiovascular Needle Market, by End User– Revenue and Forecast to 2028 (USD Thousands)
Table 13. Australia: Cardiovascular Needle Market, By Type – Revenue and Forecast to 2028 (USD Thousands)
Table 14. Australia: Cardiovascular Needle Market, by Application– Revenue and Forecast to 2028 (USD Thousands)
Table 15. Australia: Cardiovascular Needle Market, by Usage– Revenue and Forecast to 2028 (USD Thousands)
Table 16. Australia: Cardiovascular Needle Market, by End User– Revenue and Forecast to 2028 (USD Thousands)
Table 17. South Korea: Cardiovascular Needle Market, By Type – Revenue and Forecast to 2028 (USD Thousands)
Table 18. South Korea: Cardiovascular Needle Market, by Application – Revenue and Forecast to 2028 (USD Thousands)
Table 19. South Korea: Cardiovascular Needle Market, by Usage– Revenue and Forecast to 2028 (USD Thousands)
Table 20. South Korea: Cardiovascular Needle Market, by End User– Revenue and Forecast to 2028 (USD Thousands)
Table 21. Rest of Asia Pacific: Cardiovascular Needle Market, By Type – Revenue and Forecast to 2028 (USD Thousands)
Table 22. Rest of Asia Pacific: Cardiovascular Needle Market, by Application – Revenue and Forecast to 2028 (USD Thousands)
Table 23. Rest of Asia Pacific: Cardiovascular Needle Market, by Usage– Revenue and Forecast to 2028 (USD Thousands)
Table 24. Rest of Asia Pacific: Cardiovascular Needle Market, by End User– Revenue and Forecast to 2028 (USD Thousands)
Table 25. Glossary of Terms, Cardiovascular Needle Market
LIST OF FIGURES
Figure 1. Cardiovascular Needle Market Segmentation
Figure 2. Asia Pacific Cardiovascular Needle Market Overview
Figure 3. Round-Bodied Needles Segment Held Largest Share of Type in Cardiovascular Needle Market
Figure 4. Japan is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Cardiovascular Needle Market - Asia Pacific PEST Analysis
Figure 6. Cardiovascular Needle Market Impact Analysis of Driver and Restraints
Figure 7. Asia Pacific Cardiovascular Needle Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Cardiovascular Needle Market Revenue Share, by Type (2020 and 2028)
Figure 9. Round-Bodied Needles: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 10. Cutting Needles: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. Cardiovascular Needle Market Revenue Share, by Application (2020 and 2028)
Figure 12. Open Heart Surgery: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. Cardiac Valve Procedures: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. Cardiovascular Needle Market Revenue Share, by Usage (2020 and 2028)
Figure 15. Single Use: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 16. Multiple Use: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. Cardiovascular Needle Market Revenue Share, by End User (2020 and 2028)
Figure 18. Hospitals and Clinics: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. Ambulatory Surgical Centers: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 20. Cardiovascular Centers: Cardiovascular Needle Market – Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. Asia Pacific: Cardiovascular Needle Market, by Key Country – Revenue (2021) (USD Thousands)
Figure 22. Asia Pacific: Cardiovascular Needle Market, by Country, 2021 & 2028 (%)
Figure 23. China: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
Figure 24. Japan: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
Figure 25. India: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
Figure 26. Australia: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
Figure 27. South Korea: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
Figure 28. Rest of Asia Pacific: Cardiovascular Needle Market – Revenue and Forecast to 2028 (USD Thousands)
Figure 29. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Ethicon (Johnson & Johnson Services, Inc.)
- MANI, INC
- Barber of Sheffield
- FSSB surgical needles GmbH
- Medtronic
- Teleflex Incorporated
- Meril Life Sciences Pvt. Ltd.
- CP Medical
- SMB Corporation of India
- Aurolab
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific cardiovascular needle market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific cardiovascular needle market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the cardiovascular needle market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution